Dysregulation of upstream binding factor-1 acetylation at K352 is linked to impaired ribosomal DNA transcription in Huntington's disease. - Wikidata - wikimedia - TriplyDB

Dysregulation of upstream binding factor-1 acetylation at K352 is linked to impaired ribosomal DNA transcription in Huntington's disease.

Dysregulation of upstream binding factor-1 acetylation at K352 is linked to impaired ribosomal DNA transcription in Huntington's disease.

http://www.wikidata.org/entity/Q34026790

about

Nucleolar activity in neurodegenerative diseases: a missing piece of the puzzle?Nucleolar dysfunction in Huntington's disease Emerging roles of the neuronal nucleolus Perturbations at the ribosomal genes loci are at the centre of cellular dysfunction and human disease The Warsaw breakage syndrome-related protein DDX11 is required for ribosomal RNA synthesis and embryonic development Inhibition of protein translation by the DISC1-Boymaw fusion gene from a Scottish family with major psychiatric disorders.A neuroprotective phase precedes striatal degeneration upon nucleolar stress.Role of the nucleolus in neurodegenerative diseases with particular reference to the retina: a review.Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective CAG expansion induces nucleolar stress in polyglutamine diseases.Tissue-specific expression of p73 C-terminal isoforms in mice.Requirement of Neuronal Ribosome Synthesis for Growth and Maintenance of the Dendritic Tree Acetyltransferases (HATs) as targets for neurological therapeutics ESET methylates UBF at K232/254 and regulates nucleolar heterochromatin plasticity and rDNA transcription.Heterozygous De Novo UBTF Gain-of-Function Variant Is Associated with Neurodegeneration in Childhood.A link between chromatin condensation mechanisms and Huntington's disease: connecting the dots.Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA- and protein-mediated toxicities in patient cells and Drosophila.Expression of expanded CAG transcripts triggers nucleolar stress in Huntington's disease.In Vivo Translatome Profiling in Spinal Muscular Atrophy Reveals a Role for SMN Protein in Ribosome Biology.A recurrent de novo missense mutation in UBTF causes developmental neuroregression.RNA polymerase I transcription is modulated by spatial learning in different brain regions.Proapoptotic Requirement of Ribosomal Protein L11 in Ribosomal Stress-Challenged Cortical Neurons.

P2860

Q26821979-0E5D5EBA-74E4-4D8C-8B00-0AA94A322A61 Q26822451-F1834495-09F3-4962-BE95-04C3A1DE9C06 Q26863209-FC5DA1BA-510A-46F3-B547-81FE4630BE64 Q27005780-83454C43-6E95-4436-BD27-68EB5C98E762 Q28115001-B30827A2-6218-4499-ACD5-053C43590EE2 Q30399814-07D65C70-1814-46CA-A56B-AA2B5EAE2247 Q30549660-8FB7AC1A-9DD8-4CEE-A43D-AAE5854532D8 Q34045051-8DBB7E21-7F7E-4F96-ACE3-88140C3A8AAF Q35024695-8E3277A8-3B09-429C-BCA8-166900D878A1 Q36170710-4739CE74-1362-46E5-9002-D42A30E1AF0C Q36556362-49F1AD5D-28EE-41B9-B773-62187A2431EC Q36674660-5EA26AD8-D9C6-44EF-8BCA-E960B6B58DD9 Q37249167-5FFC2A42-A0D1-4A88-8D43-F08ACD42BE3F Q37574135-0A3178FF-8DF9-41A6-947A-DC5E2C5F47CA Q38640558-8FCECEC7-785B-4CE5-A287-85E7CE6EE9C7 Q38974551-1479DDAB-DBA6-458D-A95F-6C3E9085A238 Q40231204-B9D1A3F7-9996-4CBA-A673-850A0F8F7650 Q45291368-E908749C-8350-4AA8-A4D9-9CFE3BC86E81 Q47144715-1F2D49DE-34F9-4EBC-B5BC-A164D77F5B05 Q47209697-9F9B8DA2-049D-40BE-8F89-FA3A2247E88A Q49092584-DF87C7CD-2BF6-44BB-AAAA-4E90E75E5FA6 Q51263731-705024BE-94E3-47DB-9D04-2E4DB687D91A

P2860

Dysregulation of upstream binding factor-1 acetylation at K352 is linked to impaired ribosomal DNA transcription in Huntington's disease.

http://www.wikidata.org/entity/Q34026790

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Dysregulation of upstream bind ...... ption in Huntington's disease.

@ast

Dysregulation of upstream bind ...... ption in Huntington's disease.

@en

Dysregulation of upstream bind ...... ption in Huntington's disease.

@nl

type

label

Dysregulation of upstream bind ...... ption in Huntington's disease.

@ast

Dysregulation of upstream bind ...... ption in Huntington's disease.

@en

Dysregulation of upstream bind ...... ption in Huntington's disease.

@nl

prefLabel

Dysregulation of upstream bind ...... ption in Huntington's disease.

@ast

Dysregulation of upstream bind ...... ption in Huntington's disease.

@en

Dysregulation of upstream bind ...... ption in Huntington's disease.

@nl

P1433

Q34026790-E7134299-10AB-4AFA-8FC3-58CAED69507B

P1476

Q34026790-A4AE94CF-4B0B-42FE-9882-BB65C933E438

P2093

Q34026790-0E2323FA-1CCC-4BE8-B145-8E63FCC55B88

Q34026790-167D80FF-0E7C-4FF6-A080-86F0917ADB52

Q34026790-3477FB93-A5EB-497F-AAC0-C45400CECC79

Q34026790-64E1FD4D-C4B3-49BB-94D0-C5A2E8F595A0

Q34026790-78AA7DC1-9C99-453E-AEEB-4DF0FEE69E30

Q34026790-7E1696BE-4F7A-446C-9750-A16227240C9E

Q34026790-C1050DDE-7013-4BA4-9BE8-09A1DDDA3F4C

Q34026790-C3DDCC47-7D24-40CE-993A-DCAFD07B3B2F

Q34026790-E4EE3810-5C17-4D46-A9EF-829486019177

P2860

Q34026790-04673564-AF57-44B2-B8F0-B3472498711E

Q34026790-0EDE1884-1C47-4972-AAB9-BE55B01CD640

Q34026790-105C5726-865F-4BB6-998D-A183A6C710F7

Q34026790-1B3E527C-B9F6-4243-BB71-21FC545550BF

Q34026790-1D5D3C10-9BF2-47E0-99F9-A38EB94472EB

Q34026790-272216DC-1C1A-48FB-8A4D-3860D3D1786F

Q34026790-29279E22-386D-41DA-AFB2-661024BCD467

Q34026790-3C37CD0F-F7E2-4204-9809-0540ABA39171

Q34026790-3C4AC49D-2F11-43F5-B6AA-C5A87414749B

Q34026790-45252F34-50A7-4F4A-96E9-7DA83C693101

P2888

Q34026790-CAE63B4A-9335-4319-B39C-DAD396CB2829

P304

Q34026790-D23DB792-2E13-418C-831F-C3926F918036

P31

Q34026790-A5727786-CD71-40B2-A5CC-C1F679005F48

P356

Q34026790-B276762A-5123-476C-AA99-C26C4E3D867B

P433

Q34026790-A9419ECE-F52D-4B88-B46A-EB9A2570C996

P478

Q34026790-BE9BA408-3AD9-4CBA-B2DB-6DD14691E492

P577

Q34026790-D3972347-668B-4BD4-984C-B06009E80EA4

P5875

Q34026790-63CCD187-E1B5-4FA4-9F3A-8F00BEFA03C2

P698

Q34026790-5D523177-766F-4070-8633-CA714CF13D0E

P921

Q34026790-1D5A0030-25AC-4B51-8421-37184C323CF1

P932

Q34026790-BBE0ED70-CB06-40C7-A85C-31B97BDB5A05

P356

P1433

Cell Death & Differentiation

P1476

Dysregulation of upstream bind ...... ption in Huntington's disease.

@en

P2093

D Han

http://www.w3.org/2001/XMLSchema#string

H Ryu

http://www.w3.org/2001/XMLSchema#string

J H Boo

http://www.w3.org/2001/XMLSchema#string

J Lee

http://www.w3.org/2001/XMLSchema#string

K Todorova

http://www.w3.org/2001/XMLSchema#string

N W Kowall

http://www.w3.org/2001/XMLSchema#string

O K Kwon

http://www.w3.org/2001/XMLSchema#string

Y J Hwang

http://www.w3.org/2001/XMLSchema#string

Y Kim

http://www.w3.org/2001/XMLSchema#string

P2860

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases

Competitive recruitment of CBP and Rb-HDAC regulates UBF acetylation and ribosomal transcription

The giant fibrillar center: a nucleolar structure enriched in upstream binding factor (UBF) that appears in transcriptionally more active sensory ganglia neurons

UBF levels determine the number of active ribosomal RNA genes in mammals

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila

Mass spectrometric identification of phosphorylation sites of rRNA transcription factor upstream binding factor.

ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease.

Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients.

P2888

P304

1726-1735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CDD.2011.38

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51102448

http://www.w3.org/2001/XMLSchema#string

P698

21546905

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

3154516

http://www.w3.org/2001/XMLSchema#string